ConductScience.org, home

Paper36930672

COVID-19 infection, reinfection, and the transition to endemicity.

Cohen C and 1 other. Lancet, 2023. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. COVID-19 infection, reinfection, and the transition to endemicity. Papers, record 36930672. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36930672

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
COVID-19 infection, reinfection, and the transition to endemicity.
PubMed
Journal
Lancet
PubMed
Year
2023
PubMed
Publication types
Journal Article, Comment
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2023-03-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cohen CCheryl
2Pulliam JJuliet

Source PubMed

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ReinfectionMajor topic
COVID-19Major topic
Humans

Source PubMed

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on36,930,674Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.https://conductscience.org/library/papers/36930674

Source PubMed

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133,308,423Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.Lancet Public Health2021https://conductscience.org/library/papers/33308423PubMed
235,637,337An early warning system for emerging SARS-CoV-2 variants.Nat Med2022https://conductscience.org/library/papers/35637337PubMed
335,361,968Defining the risk of SARS-CoV-2 variants on immune protection.Nature2022https://conductscience.org/library/papers/35361968PubMed
435,298,900SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.Lancet Infect Dis2022https://conductscience.org/library/papers/35298900PubMed
536,355,774Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.PLoS Med2022https://conductscience.org/library/papers/36355774PubMed
636,930,674Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.Lancet2023https://conductscience.org/library/papers/36930674PubMed
736,436,752Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.Int J Infect Dis2023https://conductscience.org/library/papers/36436752PubMed
815,557,003Dynamical resonance can account for seasonality of influenza epidemics.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15557003PubMed
936,375,482Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.Lancet Microbe2022https://conductscience.org/library/papers/36375482PubMed
1035,289,632Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.Science2022https://conductscience.org/library/papers/35289632PubMed

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42,275,303Spatio-temporal modelling of COVID-19 infection and associated risk factors in Dakar, Senegal.PLOS Glob Public Health2026https://conductscience.org/library/papers/42275303PubMed
42,269,558Biochemical insights and microRNA profiling via next-generation sequencing in moderate and severe COVID-19 cases.Clinics (Sao Paulo)2026https://conductscience.org/library/papers/42269558PubMed
42,008,611Workflow‑Based Information Management Framework for Multicenter Research Studies: Design and Development.Online J Public Health Inform2026https://conductscience.org/library/papers/42008611PubMed
41,306,787Burden of SARS-CoV-2 infection and severe illness in South Africa (March 2020-August 2022): a synthesis of epidemiological data.BMJ Public Health2025https://conductscience.org/library/papers/41306787PubMed
41,286,664SARS-CoV-2 reinfection in interstitial lung disease patients and its association with clinical deterioration: a two-year prospective cohort study.BMC Infect Dis2025https://conductscience.org/library/papers/41286664PubMed
41,258,470A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023.Commun Med (Lond)2025https://conductscience.org/library/papers/41258470PubMed
41,225,355COVID-19 re-infection: a large cross-sectional population-based study in the northeast of Iran.BMC Infect Dis2025https://conductscience.org/library/papers/41225355PubMed
40,918,512Identification of gene signatures and potential pharmaceutical candidates linked to COVID-19-related depression based on gene expression profiles.Front Pharmacol2025https://conductscience.org/library/papers/40918512PubMed
40,882,614SARS-CoV-2 Antibody Prevalence Across Unvaccinated Health Care Workers During the COVID-19 Pandemic in Yemen: Cross-Sectional Study.JMIR Public Health Surveill2025https://conductscience.org/library/papers/40882614PubMed
40,751,140Clinical and immunological insights into SARS-CoV-2 reinfection: a propensity score-matched cohort study.BMC Infect Dis2025https://conductscience.org/library/papers/40751140PubMed
40,502,815The Clinical and Metabolic Profiles in Menstrual Changes Among Reproductive-Aged Women Post-COVID-19.MedComm (2020)2025https://conductscience.org/library/papers/40502815PubMed
39,839,844Evaluation of the Content Validity of the COVID-19 Symptoms Daily Diary.Patient Relat Outcome Meas2025https://conductscience.org/library/papers/39839844PubMed
39,760,090Longitudinal ozone exposure and SARS-CoV-2 infection in late pregnancy: a retrospective cohort study.Front Cell Infect Microbiol2024https://conductscience.org/library/papers/39760090PubMed
39,589,982Surface-Enhanced Raman Scattering Combined with Machine Learning for Rapid and Sensitive Detection of Anti-SARS-CoV-2 IgG.Biosensors (Basel)2024https://conductscience.org/library/papers/39589982PubMed
39,439,168Prevalence and Risk Factors of COVID-19 Reinfection in Patients with Rheumatoid Arthritis: A Retrospective Observational Study.Yonsei Med J2024https://conductscience.org/library/papers/39439168PubMed
39,349,727Developing a Coccidioides posadasii and SARS-CoV-2 Co-infection Model in the K18-hACE2 Transgenic Mouse.Commun Med (Lond)2024https://conductscience.org/library/papers/39349727PubMed
38,881,657Clinical and prognostic implications of hyaluronic acid in patients with COVID-19 reinfection and first infection.Front Microbiol2024https://conductscience.org/library/papers/38881657PubMed
38,304,972Safety and efficiency of COVID-19 vaccine in North Africa.Hum Vaccin Immunother2024https://conductscience.org/library/papers/38304972PubMed
37,750,684
Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022.
Microbiol Spectr2023https://conductscience.org/library/papers/37750684PubMed
37,174,613Understanding the Relationship of the Human Bacteriome with COVID-19 Severity and Recovery.Cells2023https://conductscience.org/library/papers/37174613PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36930672

GET https://conductscience.org/api/papers/v1/36930672/authors